Role of endothelial cells in responses of spontaneously hypertensive rat mesenteric arteries to norepinephrine and angiotensins. 1987

H Higashino, and A Suzuki, and C Su, and T J Lee
Department of Pharmacology, Kinki University School of Medicine, Osaka, Japan.

The role of endothelial cells in the constrictor and dilator responses of mesenteric arteries to infused drugs was evaluated. Fifteen- to seventeen-week-old spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY) were used. Periarterial sympathetic nerve stimulation (PNS, 6 Hz, 30 sec) elicited greater pressor responses in SHR than WKY. Acetylcholine (ACh, 1.0 microM) lowered the perfusion pressure elevated by norepinephrine (NE, 0.1 microM) significantly more in SHR than WKY. Angiotensin I and II (AI and AII, 1.0 nM) markedly potentiated the PNS-induced constriction in both animals. Collagenase perfusion (Type 1A, 2 mg/ml, 5 ml/min intermittently, for 23 min) significantly diminished the ACh-induced dilation, indicative of endothelium destruction. However, it greatly increased the constrictor effect of NE and AI and AII in SHR and the potentiating effects of AI and AII on PNS-evoked construction in both SHR and WKY, especially in SHR. These results suggest that, while endothelial cells mediate the dilator response to ACh, they are unnecessary for the constrictor and potentiating effects of NE, AI and AII and, in fact, counteract the latter two effects, particularly in the hypertensive rats. Furthermore, the endothelial cell functions promoting the effect of ACh or countering those of NE, AI and AII are in general greater in SHR than WKY.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008638 Mesenteric Arteries Arteries which arise from the abdominal aorta and distribute to most of the intestines. Arteries, Mesenteric,Artery, Mesenteric,Mesenteric Artery
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions

Related Publications

H Higashino, and A Suzuki, and C Su, and T J Lee
July 1989, Hypertension (Dallas, Tex. : 1979),
H Higashino, and A Suzuki, and C Su, and T J Lee
January 1984, Acta pathologica japonica,
H Higashino, and A Suzuki, and C Su, and T J Lee
January 1983, Hypertension (Dallas, Tex. : 1979),
H Higashino, and A Suzuki, and C Su, and T J Lee
November 1997, American journal of hypertension,
H Higashino, and A Suzuki, and C Su, and T J Lee
April 2011, Clinical and experimental pharmacology & physiology,
H Higashino, and A Suzuki, and C Su, and T J Lee
January 1983, Clinical and investigative medicine. Medecine clinique et experimentale,
H Higashino, and A Suzuki, and C Su, and T J Lee
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
H Higashino, and A Suzuki, and C Su, and T J Lee
November 2009, Circulation journal : official journal of the Japanese Circulation Society,
H Higashino, and A Suzuki, and C Su, and T J Lee
October 2009, Clinical and experimental hypertension (New York, N.Y. : 1993),
H Higashino, and A Suzuki, and C Su, and T J Lee
January 1995, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!